Cost-utility analysis of prenatal diagnosis of congenital cardiac diseases using deep learning
- PMID: 38773527
- PMCID: PMC11110271
- DOI: 10.1186/s12962-024-00550-3
Cost-utility analysis of prenatal diagnosis of congenital cardiac diseases using deep learning
Abstract
Background: Deep learning (DL) is a new technology that can assist prenatal ultrasound (US) in the detection of congenital heart disease (CHD) at the prenatal stage. Hence, an economic-epidemiologic evaluation (aka Cost-Utility Analysis) is required to assist policymakers in deciding whether to adopt the new technology.
Methods: The incremental cost-utility ratios (CUR), of adding DL assisted ultrasound (DL-US) to the current provision of US plus pulse oximetry (POX), was calculated by building a spreadsheet model that integrated demographic, economic epidemiological, health service utilization, screening performance, survival and lifetime quality of life data based on the standard formula: US screening data were based on real-world operational routine reports (as opposed to research studies). The DL screening cost of 145 USD was based on Israeli US costs plus 20.54 USD for reading and recording screens.
Results: The addition of DL assisted US, which is associated with increased sensitivity (95% vs 58.1%), resulted in far fewer undiagnosed infants (16 vs 102 [or 2.9% vs 15.4%] of the 560 and 659 births, respectively). Adoption of DL-US will add 1,204 QALYs. with increased screening costs 22.5 million USD largely offset by decreased treatment costs (20.4 million USD). Therefore, the new DL-US technology is considered "very cost-effective", costing only 1,720 USD per QALY. For most performance combinations (sensitivity > 80%, specificity > 90%), the adoption of DL-US is either cost effective or very cost effective. For specificities greater than 98% (with sensitivities above 94%), DL-US (& POX) is said to "dominate" US (& POX) by providing more QALYs at a lower cost.
Conclusion: Our exploratory CUA calculations indicate the feasibility of DL-US as being at least cost-effective.
Keywords: Congenital cardiac disease; Cost-utility analysis; Deep learning; Prenatal screening; Ultrasound.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Digital Breast Tomosynthesis with Hologic 3D Mammography Selenia Dimensions System for Use in Breast Cancer Screening: A Single Technology Assessment [Internet].Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Sep 4. Report from the Norwegian Institute of Public Health No. 2017-08. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Sep 4. Report from the Norwegian Institute of Public Health No. 2017-08. PMID: 29553669 Free Books & Documents. Review.
-
Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?Clin Orthop Relat Res. 2020 Dec;478(12):2869-2888. doi: 10.1097/CORR.0000000000001416. Clin Orthop Relat Res. 2020. PMID: 32694315 Free PMC article.
-
Cost-effectiveness of prenatal screening methods for congenital heart defects in pregnancies conceived by in-vitro fertilization.Ultrasound Obstet Gynecol. 2021 Jun;57(6):979-986. doi: 10.1002/uog.22048. Epub 2021 May 5. Ultrasound Obstet Gynecol. 2021. PMID: 32304621
-
Can Technology Assistance be Cost Effective in TKA? A Simulation-Based Analysis of a Risk-prioritized, Practice-specific Framework.Clin Orthop Relat Res. 2023 Jan 1;481(1):157-173. doi: 10.1097/CORR.0000000000002375. Epub 2022 Sep 8. Clin Orthop Relat Res. 2023. PMID: 36073992 Free PMC article.
-
The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.Tob Use Insights. 2015 Jul 14;8:1-35. doi: 10.4137/TUI.S15628. eCollection 2015. Tob Use Insights. 2015. PMID: 26242225 Free PMC article. Review.
References
-
- Su Z, Zou Z, Hay SI, Liu Y, Li S, Chen H, et al. Global, regional, and national time trends in mortality for congenital heart disease, 1990–2019: an age-period-cohort analysis for the Global Burden of Disease 2019 study. EClinicalMedicine. 2022;43:101249. doi: 10.1016/j.eclinm.2021.101249. - DOI - PMC - PubMed
-
- Ewer AK, Furmston AT, Middleton LJ, Deeks JJ, Daniels JP, Pattison HM, et al. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness. Health Technol Assess. 2012;16(2):1–184. doi: 10.3310/hta16020. - DOI - PubMed
-
- Russo CA, Elixhauser A. Hospitalizations for birth defects, 2004: statistical brief #24. 2007 Jan. In: Healthcare cost and utilization project (HCUP) statistical briefs. Rockville: Agency for Healthcare Research and Quality (US); 2006. - PubMed
LinkOut - more resources
Full Text Sources